authors
- Sands, BE
- Moss, AC
- Armuzzi, A
- Marshall, John Kenneth
- Lindsay, JO
- Sandborn, WJ
- Danese, S
- Zeroncio, M
- Modesto, I
- Salese, L
- Lawendy, N
- Zhang, H
- Su, C
Efficacy and safety of escalation to tofacitinib 10 mg BID for patients with UC following loss of response on 5 mg BID maintenance therapy: Results from OCTAVE open-label, long-term extension study
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- January 1, 2020
has subject area
- 1103 Clinical Sciences (FoR)
- Gastroenterology & Hepatology (Science Metrix)
published in
- Journal of Crohn's and Colitis Journal